Healthcare must climb the analytics maturity ladder

Last updated Dec 19, 2023

Most healthcare organizations are only halfway up the data and analytics maturity ladder.Heeding Affordable Care Act (ACA) mandates, they are instituting electronic health records (EHRs) and using analytics-derived insights to improve short-term outcomes, such as decreased hospital admissions and complications.

Related Posts

Modernizing healthcare technology for today’s needs and…

Jun 10, 2026

Infection Control & Hospital Epidemiology

Jun 9, 2026

The EHR imperative: Eliminating outages and combating cyber…

Jun 8, 2026

Prev Next 1 of 149

Related Posts

Modernizing healthcare technology for today’s needs and…

Jun 10, 2026

Infection Control & Hospital Epidemiology

Jun 9, 2026

The EHR imperative: Eliminating outages and combating cyber…

Jun 8, 2026

Post Views: 661

Continue Reading

Prev Post

The State of Healthcare analytics: Opportunities and Headwinds

Next Post

The safest place for healthcare is in the cloud

Leave A Reply

Articles

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

2026-06-12T11:00:00Z

Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2 Avail™ trial

Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting

2026-06-12T11:00:00Z

Oral presentation at JDA features new data from the KT-621 Phase 1 study in healthy Japanese adults, with safety and PK/PD results consistent with previously reported KT-621 clinical studies

BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting

2026-06-12T11:00:00Z

— Growing body of ORLADEYO® clinical data and real-world evidence demonstrates consistent reductions in HAE attack burden and healthcare utilization across diverse patient populations

Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)

2026-06-12T09:36:00Z

Basel, June 12, 2026 – Novartis today presented data from the RemIND trial at the European Academy of Allergy and Clinical Immunology (EAACI) Congress showing that Rhapsido® (remibrutinib) met its...

Evaxion receives Prix Galien UK Award for Best digital health solution

2026-06-12T07:00:00Z

COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien...

EAACI Calls for a "Vision Zero" Future Free from Allergy and Asthma Burden

2026-06-12T05:00:00Z

Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

2026-06-12T00:00:00Z

— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile —

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-06-12T00:00:00Z

DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements...

Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds

2026-06-11T22:02:43Z

New York, NY, June 11, 2026 (GLOBE NEWSWIRE) -- Leaping Straight to Neurotoxin Treatments like Botox and Dysport, NextGen Medical Aesthetics Patients Frequently Skip Lower Commitment Services

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis

2026-06-11T21:51:29Z

Santa Rosa, CA, USA, June 11, 2026 (GLOBE NEWSWIRE) -- FDA Breakthrough Device Designation Granted for XGal-3, an Investigational Apheresis Device Designed to Target Galectin-3 in Sepsis Patients

Hiding in Plain Sight: New Survey Exposes Awareness Gap Around the Second Most Common Type of Breast Cancer

2026-06-11T21:43:26Z

Boston, MA, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Despite nearly 50,000 new diagnoses each year and cases increasing faster than other breast cancer types, 4 in 5 Americans have...

Precipio to Present at the Planet MicroCap Las Vegas

2026-06-11T21:00:00Z

NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on...

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

2026-06-11T20:17:27Z

NASHVILLE, Tenn., June 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced an online published article in the American Journal of Transplantation asserting statistical superiority...

Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

2026-06-11T20:15:00Z

WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...

Crescent Biopharma Announces Grants of Inducement Awards

2026-06-11T20:15:00Z

WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies...

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

2026-06-11T20:05:00Z

GAITHERSBURG, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive...

Treace to Present at the Sidoti Small Cap Conference

2026-06-11T20:05:00Z

PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical...

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

2026-06-11T20:05:00Z

CAMBRIDGE, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet...

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

2026-06-11T20:05:00Z

SAN FRANCISCO, June 11, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced additional data from the Phase 3 MATTERHORN trial showing improvements in transfusion independence in patients with...

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

2026-06-11T20:01:00Z

PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report...

Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference

2026-06-11T20:01:00Z

LEXINGTON, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that Alfred W. Sandrock,...